Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

Back to Item »

Apeiron Nabs Option to Cleveland Clinic’s Preclincial SHP-1 Inhibitors

Firm claims preclinical studies suggest that blocking tyrosine phosphatase boosts anticancer immune response.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »